WPI Exhibiting at the 2026 MPS World Summit

WPI will be exhibiting at the 2026 Microphysiological Systems (MPS) World Summit in Washington, DC, taking place May 26–29, 2026, at the Walter E. Washington Convention Center.

The MPS World Summit brings together researchers, innovators, and industry leaders focused on advancing organ-on-chip technologies, tissue models, and next-generation in vitro systems. The meeting provides an important opportunity for collaboration across academia, biotechnology, pharmaceutical development, and regulatory science.

At this year’s event, WPI will feature technologies designed to support TEER measurement, organ-on-chip workflows, and precision microinjection applications.

Featured WPI Technologies

EVOM™ Auto

The EVOM™ Auto system delivers automated TEER measurements for evaluating cell barrier integrity in organ-on-chip devices, transwells, and tissue models. Designed for reproducibility and workflow efficiency, EVOM™ Auto helps researchers generate consistent data while reducing manual handling and variability.

EVOM™ Chip

WPI will also showcase the EVOM™ Chip platform, developed specifically for TEER measurements in microfluidic and organ-on-chip applications. The system enables researchers to monitor barrier function in dynamic microphysiological environments while integrating easily into advanced chip-based workflows.

Microinjectors

WPI’s precision microinjectors support applications including organoid manipulation, embryology, electrophysiology, and targeted delivery into microphysiological systems. Built for accuracy and control, these systems help researchers perform delicate injections with confidence and repeatability.

We look forward to connecting with researchers and industry partners throughout the event and discussing how WPI technologies support the evolving needs of MPS and organ-on-chip research.